Congratulations to Dr. Alan Davis whose recently published research shows the impact psychedelic drugs may have in several areas.

Who may benefit most from psychedelics used in therapy?

In March, Davis published research showing that patients who are open to new experiences and willing to surrender to the unknown may benefit most from psychedelics used as therapy for mental health disorders. The study can be viewed online in the journal ACS Pharmacology & Translational Science.

To read the complete press release, click here.

Davis’ research was picked up by multiple news sources including News Medical, Science Daily, Medical Xpress, Mirage News and Newswise.

One psychedelic experience may lessen trauma of racial injustice

Late last year, Davis’ also published new research showing that just one positive experience on a psychedelic drug may help reduce the lasting trauma of racial injustice in Black, Indigenous and people of color. The study can be viewed online in the journal Drugs: Education, Prevention and Policy.

To read the press release, click here.

Davis’ research was picked up in several news sources including The New York Post, Whole Foods, ANI: South Asia’s leading multimedia news agency reaching Canada and India, Yahoo!, British news outlet DailyMail.com and The College Fix.

To learn more about Davis, click here.